Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.55M | 2.50M | 2.58M | 2.57M | 2.18M |
| Total Other Revenue | -- | -- | -7.50K | -7.50K | 7.40K |
| Total Revenue | 2.55M | 2.50M | 2.57M | 2.56M | 2.18M |
| Cost of Revenue | 1.45M | 1.42M | 1.57M | 1.56M | 1.52M |
| Gross Profit | 1.10M | 1.08M | 1.00M | 1.00M | 660.80K |
| SG&A Expenses | 1.19M | 1.16M | 1.58M | 1.57M | 1.38M |
| Depreciation & Amortization | 132.80K | 129.80K | 117.50K | 117.10K | 163.70K |
| Other Operating Expenses | 6.70K | 6.60K | -90.60K | -90.30K | 107.30K |
| Total Operating Expenses | 2.78M | 2.71M | 3.17M | 3.16M | 3.17M |
| Operating Income | -222.20K | -217.30K | -597.90K | -596.00K | -988.10K |
| Income Before Tax | -345.40K | -337.70K | -965.50K | -962.40K | -942.00K |
| Income Tax Expenses | -- | -- | -175.60K | -175.00K | -- |
| Earnings from Continuing Operations | -345.40K | -337.70K | -789.90K | -787.40K | -942.00K |
| Earnings from Discontinued Operations | -34.80K | -34.00K | -- | -- | -48.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -380.20K | -371.70K | -789.90K | -787.40K | -990.70K |
| EBIT | -222.20K | -217.30K | -597.90K | -596.00K | -988.10K |
| EBITDA | -89.50K | -87.50K | -508.70K | -507.10K | -824.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 413.99M | 413.99M | 290.26M | 290.26M | 222.16M |
| Average Diluted Shares Outstanding | 413.99M | 413.99M | 290.26M | 290.26M | 222.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |